FDA Releases Five-Year Plan for Sentinel System

Drug Industry Daily
A A
The FDA unveiled a five-year strategy on Wednesday for its Sentinel post-market safety surveillance system, detailing major goals through the year 2023.

To View This Article:

Login

Subscribe To Drug Industry Daily